THURSDAY, SEPTEMBER 29, 2016

BIO endorses Vaccine Access, Certainty and Innovation Act bill

BIO endorses Vaccine Access, Certainty and Innovation Act legislation. | Courtesy of patentbaristas.com

The Biotechnology Industry Organization (BIO) recently praised the introduction of Vaccine Access, Certainty and Innovation Act legislation in the U.S. House.

The bill, sponsored by Reps. G.K. Butterfield (D-NC) and Renee Ellmers (R-NC), would have an important role in the Energy and Commerce Committee's 21st Century Cures initiative. The bill may be crucial to developing, producing and administering vaccines, and will change many aspects of vaccines and public health around the world.

Overall, the act would encourage novel vaccine research and make vaccines more easily accessible for patients around the world.

The act also would ensure that the Advisory Committee on Immunization Practices (ACIP) shows integrity and honesty in its vaccine recommendations. The act would enforce formal meetings between vaccine developers and the CDC through the development process of vaccines, ensuring that all officials and scientists have the same priorities.

Vaccines would be accessible to the public, as the act would order Medicare to cover the vaccines.

The act would require Health and Human Services to guide vaccine development and licensure. In addition, it would require a thorough review of current vaccine programs, as well as reinforce and acknowledge the role of the National Institutes of Health in research and development.

“As much progress as vaccines have enabled us to make, much more work remains to be done,” Jim Greenwood, president and CEO of BIO, said. “New vaccines are still needed in many areas, including against global infectious diseases like TB, malaria and HIV; emerging infectious diseases like Ebola and Marburg; and against methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infectious agents.”

“I thank Representatives Ellmers and Butterfield for their leadership in authoring and sponsoring this important legislation,” Greenwood said. “We look forward to continuing to work with them and their colleagues on the House Energy and Commerce Committee on this bill, as well as other components of the 21st Century Cures Initiative.”

Organizations in this story

The Biotechnology Industry Organization 1201 Maryland Ave SW Suite 900 Washington, DC 20024

National Institutes of Health 9000 Rockville Pike Bethesda, MD 20892

Get notified the next time we write about any of these organizations!